S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

MCRB Seres Therapeutics Inc

0.8318

0.0267 (3.32%)

Last Updated: 11:27:11

Delayed by 15 minutes

Form 8-K - Current report

Seres Therapeutics (NASDAQ:MCRB)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Seres Therapeutics Charts.

Seres Therapeutics (NASDAQ:MCRB)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Seres Therapeutics Charts.

Seres Therapeutics Inc News

Seres Therapeutics Announces Receipt of Expected $50 Million Installment Payment Related to VOWST Sale
Thursday 16 January 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 13 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 10 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Seres Therapeutics Announces New Translational Biomarker Results from SER-155 Phase 1b Clinical Study and Provides Corporate Updates
Thursday 9 January 2025 (3 weeks ago) • GlobeNewswire Inc.

Seres Therapeutics to Participate in 2025 J.P. Morgan Healthcare Conference
Monday 16 December 2024 (1 month ago) • GlobeNewswire Inc.

FDA Grants Breakthrough Therapy Designation to Seres Therapeutics’ SER-155 for Reduction of Bloodstream Infections in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT)
Monday 9 December 2024 (2 months ago) • GlobeNewswire Inc.

Seres Therapeutics to Participate in Piper Sandler Healthcare Conference
Friday 22 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 19 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 19 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 19 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 13 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 13 November 2024 (3 months ago) • Edgar (US Regulatory)

More Seres Therapeutics Inc News Articles

NioCorp Developments

Green Leaf Innovations (PK)

Clean Vision (QB)

RespireRx Pharmaceuticals (CE)

Digital Brand Media and ... (PK)

UAV Corpoation (PK)

Voip Pal Com (QB)

Code Green Apparel (PK)

AMC Entertainment

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions